Your browser doesn't support javascript.
Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.
Fukumoto, Tatsuya; Iwasaki, Sumio; Fujisawa, Shinichi; Hayasaka, Kasumi; Sato, Kaori; Oguri, Satoshi; Taki, Keisuke; Nakakubo, Sho; Kamada, Keisuke; Yamashita, Yu; Konno, Satoshi; Nishida, Mutsumi; Sugita, Junichi; Teshima, Takanori.
  • Fukumoto T; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Iwasaki S; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Fujisawa S; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Hayasaka K; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Sato K; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Oguri S; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Taki K; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Nakakubo S; Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Kamada K; Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Yamashita Y; Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Konno S; Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Nishida M; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Sugita J; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
  • Teshima T; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan. Electronic address: teshima@med.hokudai.ac.jp.
Int J Infect Dis ; 98: 16-17, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-624246
ABSTRACT
Rapid detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for the diagnosis of coronavirus disease 2019 (COVID-19) and preventing the spread of the virus. A novel detection kit - the 2019 Novel Coronavirus Detection Kit (nCoV-DK) - halves the detection time by eliminating the steps of RNA extraction and purification. We evaluated the concordance between the nCoV-DK and direct PCR. The virus was detected in 53/71 specimens (74.6%) by direct PCR and in 55/71 specimens (77.5%) by nCoV-DK; the overall concordance rate was 94.4% 95.2% for nasopharyngeal swab, 95.5% for saliva, and 85.7% for sputum. The nCoV-DK test effectively detects SARS-CoV-2 in all types of sample including saliva, while reducing the time required for detection, labor, and the risk of human error.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Clinical Laboratory Techniques / Diagnostic Tests, Routine / Betacoronavirus Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: J.ijid.2020.06.074

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Clinical Laboratory Techniques / Diagnostic Tests, Routine / Betacoronavirus Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: J.ijid.2020.06.074